And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

KNSA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 54.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,514,569.65

Kiniksa Pharmaceuticals Insider Trading History Chart

Kiniksa Pharmaceuticals Share Price & Price History

^$20.26

▼ -0.07 (-0.34%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

AI “wealth window” is closing June 25th

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Kiniksa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2024	Sanj K Patel	CEO	Sell	5,582	$21.00	$117,222.00	65,012
3/4/2024	Sanj K Patel	CEO	Sell	12,742	$21.49	$273,825.58	70,594
3/1/2024	Michael R Megna	CAO	Sell	9,659	$21.45	$207,185.55	17,588
2/28/2024	Michael R Megna	CAO	Sell	5,126	$21.79	$111,695.54	17,588
1/3/2024	Mark Ragosa	CFO	Sell	12,000	$20.00	$240,000.00	15,632
1/2/2024	Michael R Megna	CAO	Sell	16,670	$19.17	$319,563.90	17,005
12/19/2023	Michael R Megna	CAO	Sell	9,316	$19.13	$178,215.08	17,005
12/7/2023	John F Paolini	Insider	Sell	28,600	$17.65	$504,790.00	44,892
9/5/2023	John F Paolini	Insider	Sell	400	$17.53	$7,012.00	44,892
7/25/2023	John F Paolini	Insider	Sell	29,000	$19.14	$555,060.00	41,910
11/29/2022	Barry D. Quart	Director	Sell	21,959	$16.15	$354,637.85

AI “wealth window” is closing June 25th

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

53.95% of Kiniksa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kiniksa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/9/2024	State Board of Administration of Florida Retirement System	13,467	$0.27M	0.0%	N/A	0.019%
5/8/2024	QRG Capital Management Inc.	15,178	$0.30M	0.0%	-5.2%	0.021%
5/7/2024	Sei Investments Co.	73,481	$1.45M	0.0%	N/A	0.104%
5/7/2024	SG Americas Securities LLC	19,160	$0.38M	0.0%	+8.1%	0.027%
5/3/2024	Essex Investment Management Co. LLC	172,740	$3.41M	0.7%	+0.5%	0.245%
5/2/2024	Nordea Investment Management AB	126,742	$2.49M	0.0%	N/A	0.179%
5/2/2024	Hussman Strategic Advisors Inc.	157,500	$3.11M	0.7%	N/A	0.223%
5/1/2024	Janney Montgomery Scott LLC	26,843	$0.53M	0.0%	+7.8%	0.038%
5/1/2024	BNP Paribas Financial Markets	46,060	$0.91M	0.0%	-39.9%	0.065%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	20,935	$0.41M	0.0%	+5.8%	0.030%
4/29/2024	Principal Financial Group Inc.	58,991	$1.16M	0.0%	+42.7%	0.084%
4/29/2024	China Universal Asset Management Co. Ltd.	7,708	$0.15M	0.0%	+88.1%	0.011%
4/26/2024	Peregrine Capital Management LLC	236,045	$4.66M	0.1%	N/A	0.334%
4/23/2024	Rice Hall James & Associates LLC	618,798	$12.21M	0.7%	-2.7%	0.876%
4/18/2024	Allspring Global Investments Holdings LLC	61,106	$1.21M	0.0%	+18.4%	0.087%
4/17/2024	Hennion & Walsh Asset Management Inc.	124,878	$2.46M	0.1%	+29.2%	0.177%
4/5/2024	Los Angeles Capital Management LLC	139,850	$2.76M	0.0%	-5.0%	0.198%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	227,500	$3.99M	0.0%	-6.2%	0.322%
2/15/2024	Opaleye Management Inc.	37,500	$0.64M	0.2%	N/A	0.053%
2/15/2024	Parkman Healthcare Partners LLC	615,693	$10.80M	1.5%	+20.8%	0.875%
2/15/2024	Granahan Investment Management LLC	722,388	$12.67M	0.4%	+35.2%	1.027%
2/14/2024	ADAR1 Capital Management LLC	105,000	$1.84M	0.7%	N/A	0.149%
2/14/2024	Altitude Crest Partners Inc.	456,041	$8M	5.4%	N/A	0.648%
2/14/2024	Rubric Capital Management LP	2,907,501	$51M	1.1%	-5.5%	4.133%
2/13/2024	Rafferty Asset Management LLC	95,855	$1.68M	0.0%	-31.1%	0.136%
2/13/2024	Campbell & CO Investment Adviser LLC	23,182	$0.41M	0.0%	-27.3%	0.033%
2/9/2024	Trexquant Investment LP	71,550	$1.26M	0.0%	-6.9%	0.102%
2/9/2024	Dynamic Technology Lab Private Ltd	12,160	$0.21M	0.0%	N/A	0.017%
2/8/2024	Janney Montgomery Scott LLC	24,903	$0.44M	0.0%	N/A	0.035%
2/8/2024	Essex Investment Management Co. LLC	171,890	$3.02M	0.6%	-7.5%	0.244%
2/8/2024	Massachusetts Financial Services Co. MA	75,650	$1.33M	0.0%	-3.1%	0.108%
2/7/2024	Principal Financial Group Inc.	41,332	$0.73M	0.0%	-7.6%	0.059%
2/7/2024	QRG Capital Management Inc.	16,010	$0.28M	0.0%	+11.7%	0.023%
2/7/2024	Jump Financial LLC	54,220	$0.95M	0.0%	N/A	0.077%
2/7/2024	BNP Paribas Financial Markets	76,668	$1.35M	0.0%	+11.4%	0.109%
2/6/2024	M&T Bank Corp	36,412	$0.64M	0.0%	-1.6%	0.052%
2/6/2024	Los Angeles Capital Management LLC	147,182	$2.58M	0.0%	+1.1%	0.209%
2/6/2024	Swiss National Bank	55,600	$0.98M	0.0%	-8.4%	0.079%
2/5/2024	Victory Capital Management Inc.	14,653	$0.26M	0.0%	+45.0%	0.021%
2/1/2024	Linden Thomas Advisory Services LLC	114,550	$2.01M	0.4%	-1.2%	0.163%
2/1/2024	New York State Common Retirement Fund	34,867	$0.61M	0.0%	+148.6%	0.050%
1/30/2024	Strs Ohio	33,300	$0.58M	0.0%	-5.4%	0.047%
1/25/2024	Allspring Global Investments Holdings LLC	51,616	$0.91M	0.0%	-16.1%	0.073%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	19,782	$0.35M	0.0%	-5.5%	0.028%
1/24/2024	China Universal Asset Management Co. Ltd.	4,097	$72K	0.0%	+349.7%	0.006%
1/12/2024	SG Americas Securities LLC	17,725	$0.31M	0.0%	N/A	0.025%
12/18/2023	Vanguard Group Inc.	2,958,957	$51.40M	0.0%	-4.2%	4.207%
12/7/2023	Hudson Bay Capital Management LP	302,500	$5.25M	0.0%	-55.5%	0.430%
11/15/2023	Tejara Capital Ltd	35,000	$0.61M	0.3%	+3.2%	0.050%
11/15/2023	GSA Capital Partners LLP	63,216	$1.10M	0.1%	+81.9%	0.090%
11/15/2023	Alps Advisors Inc.	71,103	$1.24M	0.0%	+38.3%	0.101%
11/15/2023	AQR Capital Management LLC	323,578	$5.62M	0.0%	-36.7%	0.460%
11/14/2023	Schonfeld Strategic Advisors LLC	208,500	$3.62M	0.0%	+180.1%	0.296%
11/14/2023	Rubric Capital Management LP	3,077,449	$53.46M	2.0%	-8.9%	4.375%
11/14/2023	Trexquant Investment LP	76,823	$1.33M	0.0%	-10.8%	0.109%
11/14/2023	Profund Advisors LLC	23,506	$0.41M	0.0%	+7.8%	0.033%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	256,932	$4.46M	0.0%	+59.9%	0.365%
11/13/2023	EAM Investors LLC	124,438	$2.16M	0.4%	N/A	0.177%
11/13/2023	Dark Forest Capital Management LP	65,029	$1.13M	0.1%	N/A	0.092%
11/13/2023	Acadian Asset Management LLC	226,181	$3.92M	0.0%	+916.6%	0.322%
11/13/2023	WINTON GROUP Ltd	22,504	$0.39M	0.0%	N/A	0.032%
11/13/2023	QRG Capital Management Inc.	14,331	$0.25M	0.0%	N/A	0.020%
11/13/2023	Rafferty Asset Management LLC	139,106	$2.42M	0.0%	+16.5%	0.198%
11/9/2023	Deutsche Bank AG	91,726	$1.59M	0.0%	+2.5%	0.131%
11/9/2023	Essex Investment Management Co. LLC	185,853	$3.23M	0.5%	-1.3%	0.265%
11/8/2023	Campbell & CO Investment Adviser LLC	31,895	$0.55M	0.1%	-44.3%	0.045%
11/8/2023	Massachusetts Financial Services Co. MA	78,042	$1.36M	0.0%	-3.7%	0.111%
11/7/2023	Virtus ETF Advisers LLC	18,461	$0.32M	0.2%	-11.5%	0.026%
11/7/2023	Barclays PLC	175,525	$3.05M	0.0%	+7.9%	0.250%
11/6/2023	Los Angeles Capital Management LLC	145,642	$2.53M	0.0%	-9.2%	0.208%
11/6/2023	Victory Capital Management Inc.	10,106	$0.18M	0.0%	N/A	0.014%
11/4/2023	Capula Management Ltd	51,340	$0.89M	0.0%	N/A	0.073%
11/2/2023	Rice Hall James & Associates LLC	650,366	$11.30M	0.7%	-1.5%	0.927%
11/2/2023	Principal Financial Group Inc.	44,724	$0.78M	0.0%	N/A	0.064%
11/2/2023	M&T Bank Corp	37,013	$0.64M	0.0%	-35.4%	0.053%
10/27/2023	Hennion & Walsh Asset Management Inc.	55,047	$0.96M	0.1%	+89.5%	0.078%
10/27/2023	Allspring Global Investments Holdings LLC	61,532	$1.07M	0.0%	-83.2%	0.088%
10/26/2023	Strs Ohio	35,200	$0.61M	0.0%	-5.6%	0.050%
10/24/2023	Bank of New York Mellon Corp	146,568	$2.55M	0.0%	+13.8%	0.209%
10/20/2023	Linden Thomas Advisory Services LLC	115,891	$2.01M	0.4%	+100.0%	0.165%
10/12/2023	IFP Advisors Inc	3,750	$65K	0.0%	N/A	0.005%
10/12/2023	Legato Capital Management LLC	66,918	$1.16M	0.2%	-4.5%	0.095%
8/18/2023	Legato Capital Management LLC	70,061	$0.99M	0.1%	+48.1%	0.100%
8/15/2023	Hudson Bay Capital Management LP	680,000	$9.57M	0.1%	-20.9%	0.969%
8/14/2023	ArrowMark Colorado Holdings LLC	985,196	$13.87M	0.2%	+11.1%	1.404%
8/14/2023	Granahan Investment Management LLC	536,429	$7.55M	0.2%	-6.7%	0.764%
8/11/2023	Rubric Capital Management LP	3,378,164	$47.57M	2.0%	+21.7%	4.833%
8/11/2023	Campbell & CO Investment Adviser LLC	57,274	$0.81M	0.1%	+95.9%	0.082%
8/11/2023	Trexquant Investment LP	86,096	$1.21M	0.0%	+114.2%	0.123%
8/11/2023	Tejara Capital Ltd	33,931	$0.48M	0.2%	-30.0%	0.049%
8/10/2023	Profund Advisors LLC	21,806	$0.31M	0.0%	-9.6%	0.031%
8/9/2023	BNP Paribas Arbitrage SNC	78,875	$1.11M	0.0%	-37.7%	0.113%
8/8/2023	AlphaCentric Advisors LLC	110,000	$1.55M	0.9%	+33.3%	0.157%
8/7/2023	Acadian Asset Management LLC	22,248	$0.31M	0.0%	+29.7%	0.032%
8/4/2023	Cornerstone Investment Partners LLC	10,474	$0.15M	0.0%	N/A	0.015%
8/3/2023	Los Angeles Capital Management LLC	160,394	$2.26M	0.0%	+41.1%	0.229%
8/3/2023	Bank of New York Mellon Corp	128,778	$1.81M	0.0%	+0.6%	0.184%
8/3/2023	Jackson Creek Investment Advisors LLC	65,654	$0.92M	0.4%	+6.6%	0.094%
7/31/2023	Strs Ohio	37,300	$0.53M	0.0%	-23.3%	0.053%
7/27/2023	Linden Thomas Advisory Services LLC	57,949	$0.82M	0.2%	N/A	0.083%

Data available starting January 2016

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was incorporated in 2015 and is based in Hamilton, Bermuda.

Today's Range

Now: $20.26

$20.02

$20.38

50 Day Range

MA: $19.14

$16.88

$21.74

52 Week Range

Now: $20.26

$13.02

$22.09

Volume

272,503 shs

Average Volume

404,867 shs

Market Capitalization

$1.44 billion

P/E Ratio

184.20

Dividend Yield

N/A

Beta

0.32

Who are the company insiders with the largest holdings of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top insider shareholders include:
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Barry D Quart (Director)
Learn More about top insider investors at Kiniksa Pharmaceuticals.
Who are the major institutional investors of Kiniksa Pharmaceuticals?: Kiniksa Pharmaceuticals' top institutional shareholders include:
Rice Hall James & Associates LLC — 0.88%
Peregrine Capital Management LLC — 0.33%
Essex Investment Management Co. LLC — 0.24%
Hussman Strategic Advisors Inc. — 0.22%
Los Angeles Capital Management LLC — 0.20%
Nordea Investment Management AB — 0.18%
Learn More about top institutional investors of Kiniksa Pharmaceuticals stock.
Which major investors are selling Kiniksa Pharmaceuticals stock?: During the last quarter, KNSA stock was sold by these institutional investors:
BNP Paribas Financial Markets
Rice Hall James & Associates LLC
Los Angeles Capital Management LLC
QRG Capital Management Inc.
During the previous year, company insiders that have sold Kiniksa Pharmaceuticals company stock include:
Sanj K Patel (CEO)
John F Paolini (Insider)
Michael R Megna (CAO)
Mark Ragosa (CFO)
Learn More investors selling Kiniksa Pharmaceuticals stock.
Which major investors are buying Kiniksa Pharmaceuticals stock?: In the previous quarter, KNSA stock was bought by institutional investors including:
Peregrine Capital Management LLC
Hussman Strategic Advisors Inc.
Nordea Investment Management AB
Sei Investments Co.
Hennion & Walsh Asset Management Inc.
Principal Financial Group Inc.
State Board of Administration of Florida Retirement System
Allspring Global Investments Holdings LLC

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here